Vergoeding 2017-2021 voor ATC-subgroep A10BJ : Glucagonachtig peptide-1-agonisten (glp-1-agonisten)

  • Raming voor de totale Zvw-populatie
  2017 2018 2019 2020 2021
A10BJ01 Exenatide (Bydureon ®) 1.006.400 879.410 730.960 588.480 477.290
A10BJ02 Liraglutide (Victoza ®) 12.166.300 13.666.600 13.784.700 11.632.600 9.263.200
A10BJ03 Lixisenatide (Lyxumia ®) 51.647 90.202 83.417 65.761 43.015
A10BJ05 Dulaglutide (Trulicity ®) 1.699.200 2.757.000 2.640.300 3.586.600 4.397.900
A10BJ06 Semaglutide (Ozempic ®) . 380.020 9.289.300 24.153.100 36.065.100
Totaal 14.923.547 17.773.232 26.528.677 40.026.541 50.246.505